期刊文献+

Inappropriate use of digoxin in patients presenting with digoxin toxicity 被引量:2

Inappropriate use of digoxin in patients presenting with digoxin toxicity
下载PDF
导出
摘要 尽管有它的狭窄的治疗学的索引和毒性, BackgroundDigoxin 遗体今天广泛地使用了。学习是调查异羟基洋地黄毒苷的不恰当的使用和老病人的长期的结果的百分比的这的目的就医了因为异羟基洋地黄毒苷 toxicity.MethodsThe 学习包括了为异羟基洋地黄毒苷毒性就医的 99 个连续病人。如果参加者压抑左室的收缩功能,为异羟基洋地黄毒苷的不恰当的使用的另外的学习标准被考虑(喷射部分 <45%) 不在包括贝它块和 angiotensin-converting-enzyme 禁止者治疗的最佳的医药治疗上或如果参加者有永久 AF 尽管有它的狭窄的治疗学的索引,不在最佳的贝它块 therapy.ResultsAppropriate 异羟基洋地黄毒苷用法上的人,在 33 个病人被证实。99 个病人中的 16 个的一个总数死了,与 22.1 &#x000b1 的一吝啬的后续时间;10.3 months.ConclusionsContrary 到流行信仰,不恰当的异羟基洋地黄毒苷用法的率仍然保持高。由于它的狭窄的治疗学的索引和毒性,异羟基洋地黄毒苷应该根据当前的证据和指南更小心地被使用。 Background Digoxin remains widely used today despite its narrow therapeutic index and toxicity. The objective of this study was to investigate the percentage of inappropriate use of digoxin and long-term outcomes of elderly patients hospitalized for digoxin toxicity. Methods The study included 99 consecutive patients hospitalized for digoxin toxicity. The other study criteria for the inappropriate use of digoxin was regarded if participants having depressed left ventricular systolic function (ejection fraction 〈 45%) who were not on optimal medical therapy including beta-blocker and angiotensin-converting-enzyme inhibitor therapy or if participants having permanent AF who were not on optimal beta-blocker therapy. Results Appropriate digoxin usage was confirmed in 33 of patients in spite of its narrow therapeutic index. A total of 16 of 99 patients died, with a mean follow-up time of 22.1 ± 10.3 months. Conclusions Contrary to popular belief, the rate of inappropriate digoxin usage remains high. On account of its narrow therapeutic index and toxicity, digoxin should be used more carefully according to the current evidence and guidelines.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2015年第2期143-146,共4页 老年心脏病学杂志(英文版)
  • 相关文献

参考文献12

  • 1McMurray 33, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatmem of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in. collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
  • 2Camm A J, Kirchhof P, Lip GY, et al. Guidelines for themanagement of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1420.
  • 3Lip GY, Metcalfe MJ, Dunn FG. Diagnosis and treatment of digoxin toxicity. Postgrad MedJ 1993; 69: 337-339.
  • 4Mann DL. Management of patients with heart failure with re- duced ejection fraction, 10~ Edition; Mann DL, Zipes DP, Lib- by P, et al, Elsevier Saunders; 2015: 534.
  • 5Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 Com- prehensive heart failure practice guideline. J Card Fail 2010; 16: 1.
  • 6Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289: 871.
  • 7Gheorghiade M, Adams KF Jr., Colucci WS. Digoxin in the management of cardiovascular disorders. Circulation 2004; 109: 2959.
  • 8Bourge RC, Fleg JL, Fonarow GC, et al. Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am JMed2013; 126: 701.
  • 9Aronow WS. Prevalence of appropriate and inappropriate indi- cations for use of digoxin in older patients at the time of admis- sion to a nursing home. JAm Geriatr Soc 1996; 44: 588-590.
  • 10Ahmed A, Allman RM, DeLong JF. Inappropriate use of digoxin in older hospitalized heart failure patients. J Gerontol A Biol Sci MedSci 2002; 57: 138-143.

同被引文献5

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部